Man Group PLC Mei Pharma, Inc. Transaction History

Man Group PLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.41 - $8.8 $1,599 - $34,337	3,902 Added 21.71%	21,872 $8,000
Q2 2022 Aug 15, 2022	BUY	$0.42 - $0.65 $7,547 - $11,680	17,970 New	17,970 $11,000
Q1 2022 May 16, 2022	SELL	$0.54 - $2.74 $18,954 - $96,174	-35,100 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$2.33 - $3.37 $53,124 - $76,836	22,800 Added 185.37%	35,100 $94,000
Q3 2021 Nov 15, 2021	BUY	$2.52 - $2.99 $30,996 - $36,777	12,300 New	12,300 $34,000

Ticker MEIP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 133,261,000
Market Cap $385M
Description
MEI Pharma, Inc., a late-stage pharmaceutical company, focuses on the development and commercialization of various therapies for the treatment of cancer. The company develops Zandelisib, an oral phosphatidylinositol 3-kinase delta inhibitor that is in Phase III clinical trial for the treatment of patients with relapsed/refractory follicular lymp...

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

Stay updated on Man Group PLC with notifications on news.